Sit Investment Associates Inc. increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 23.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,374 shares of the biotechnology company’s stock after purchasing an additional 1,574 shares during the quarter. Sit Investment Associates Inc.’s holdings in Axon Enterprise were worth $4,756,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Evergreen Capital Management LLC grew its stake in Axon Enterprise by 3.8% during the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock worth $342,000 after buying an additional 15 shares during the period. Wealth Alliance LLC raised its stake in shares of Axon Enterprise by 3.2% in the 3rd quarter. Wealth Alliance LLC now owns 583 shares of the biotechnology company’s stock valued at $419,000 after acquiring an additional 18 shares during the period. Quadrant Capital Group LLC raised its stake in shares of Axon Enterprise by 0.5% in the 3rd quarter. Quadrant Capital Group LLC now owns 3,968 shares of the biotechnology company’s stock valued at $2,848,000 after acquiring an additional 19 shares during the period. CWA Asset Management Group LLC lifted its holdings in shares of Axon Enterprise by 5.2% during the 4th quarter. CWA Asset Management Group LLC now owns 387 shares of the biotechnology company’s stock valued at $220,000 after acquiring an additional 19 shares in the last quarter. Finally, Synergy Financial Group LTD lifted its holdings in shares of Axon Enterprise by 1.4% during the 3rd quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company’s stock valued at $996,000 after acquiring an additional 19 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.
Axon Enterprise Stock Performance
AXON opened at $423.40 on Friday. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The stock has a market capitalization of $34.13 billion, a PE ratio of 170.04, a P/E/G ratio of 7.70 and a beta of 1.45. The firm’s fifty day moving average price is $413.25 and its 200 day moving average price is $485.61.
Analysts Set New Price Targets
A number of brokerages recently weighed in on AXON. Zacks Research raised shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 19th. Barclays reduced their price objective on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research note on Friday, May 8th. Piper Sandler reaffirmed an “overweight” rating and issued a $674.00 target price on shares of Axon Enterprise in a research report on Monday. Morgan Stanley set a $600.00 target price on Axon Enterprise in a research note on Thursday, May 7th. Finally, Weiss Ratings upgraded Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.
Read Our Latest Stock Report on Axon Enterprise
Insider Buying and Selling at Axon Enterprise
In related news, President Joshua Isner sold 13,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the sale, the president directly owned 169,125 shares of the company’s stock, valued at $82,609,106.25. The trade was a 7.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the sale, the executive owned 49,710 shares in the company, valued at $24,855,000. The trade was a 2.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 38,989 shares of company stock valued at $19,090,083. Corporate insiders own 4.20% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Read More
- Five stocks we like better than Axon Enterprise
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
